NCT05981053 is a clinical trial of Wine enriched with Resveratrol in Aging, sponsored by PINER Pastor Manfredi Winery.

Who is sponsoring NCT05981053?

NCT05981053 is sponsored by PINER Pastor Manfredi Winery.

What drugs are being tested in NCT05981053?

Interventions in NCT05981053: Wine enriched with Resveratrol.

What condition does NCT05981053 study?

NCT05981053 studies Aging, Healthy Aging, Sarcopenia, Obesity.

Is NCT05981053 still recruiting?

NCT05981053 is currently completed. Last updated 8 August 2023.

Last reviewed 2023-08-08 · How we verify

NCT05981053

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biological Effects in Consumers of Resveratrol-enriched Wine

Completed Last updated 8 August 2023

What this trial tests

trial testing Wine enriched with Resveratrol in Aging in 30 participants. Completed in 30 June 2023.

Timeline

15 July 2022

Primary endpoint
28 April 2023

30 June 2023

Quick facts

Lead sponsor	PINER Pastor Manfredi Winery
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	15 July 2022
Primary completion	28 April 2023
Estimated completion	30 June 2023
Sites	1 location across Argentina

Drugs / interventions tested

Wine enriched with Resveratrol

Conditions studied

Aging — all drugs for Aging →
Healthy Aging — all drugs for Healthy Aging →
Sarcopenia — all drugs for Sarcopenia →
Obesity — all drugs for Obesity →

Sponsor

PINER Pastor Manfredi Winery

Who can join

Adults 40 to 80, any sex, with Aging or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical trial is to compare the health conditions of the participating population before and after an intervention with Resveratrol enriched wine. The main questions it aims to answer are: 1. • The consumption of wine enriched with resveratrol could slow down or reverse the biological age ? 2. • The consumption of wine enriched with resveratrol could improve body composition fat mass / muscle mass ? The participants will be evaluated at the beginning and at the end of the clinical trial and will adopt only one change in their habits, that is, change the usual wine they consume with their meals for a wine enriched with resveratrol, in a moderate measure, 250 cc for men and 125 cc/day for women. The design of the study will be that each volunteer is their own control, pre and post intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration.
Trisal A, Singh AK. · · 2024 · cited 9× · PMID 39412683 · DOI 10.1007/s10571-024-01493-2
Epigenetic Regulation of Aging and its Rejuvenation.
An Y, Wang Q, Gao K, Zhang C, et al · · 2025 · cited 5× · PMID 40904701 · DOI 10.1002/mco2.70369

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other PINER Pastor Manfredi Winery trials

Trials by the same sponsor.

NCT07530575 — Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05981053 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PINER Pastor Manfredi Winery
Last refreshed: 8 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05981053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing